SLC12A5 and central nervous system cancer: Translating these findings to glioma, it should be noted that glutamate concentrations in the tumor microenvironment can easily surpass 100 μM [32], and thus robustly downregulate KCC2 levels and shift GABA from an inhibitory to functionally excitatory neurotransmitter.